Verb Surgical™ is working with physicians around the world to create the future of surgery. A new future, a future unimagined even a few years ago, which will involve machine learning, robotic surgery, instrumentation, advanced visualization, and data analytics. A future of surgery that aims to achieve improved patient outcomes, lower costs, and greater hospital efficiency.
Verb Surgical was founded with technology, expertise, and funding from Verily (formerly Google Life Sciences) and Ethicon, a medical device company in the Johnson & Johnson family of companies. This company will continue in strong partnership with Verily and Johnson & Johnson (Google and Johnson & Johnson Team for Robotic Surgery) to advance the surgical tools and capabilities available to surgeons and OR professionals today.
The microvascular practice of the future will require subspecialization, collaborative team effort, an academic medical center, regional prominence, and a large catchment population, as well as a health system that funnels patients from hospital networks outside the region. Dexterity and meticulous application of microsurgical technique will remain the fundamental skills of the open vascular neurosurgeon 1).